Thrombosis News and Research

Latest Thrombosis News and Research

Engineered nanodroplets and ultrasound 'drill' can help eliminate tough blood clots

Engineering researchers have developed a new technique for eliminating particularly tough blood clots, using engineered nanodroplets and an ultrasound "drill" to break up the clots from the inside out.

7 Jan 2021

FDA authorizes first device to treat patients with walled-off pancreatic necrosis

Today, the U.S. Food and Drug Administration authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis (WOPN), a potentially deadly condition which can occur several weeks after an episode of severe acute pancreatitis, often requiring tissue removal.

23 Dec 2020

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.

23 Dec 2020

New toolkit aims to maximize high-quality collection of thrombosis data in COVID-19 clinical studies

The ASH Research Collaborative and the International Society of Haemostasis and Thrombosis, two organizations with multidisciplinary expertise in blood clotting and bleeding disorders, have developed a toolkit to help clinical researchers from across medical disciplines design clinical trials that further the understanding of blood clotting events associated with COVID-19.

17 Dec 2020

Oral contraceptives offer a protective effect against common gynecological cancers

A comprehensive study from Uppsala University, involving more than 250,000 women, shows that oral contraceptive use protects against ovarian and endometrial cancer. The protective effect remains for several decades after discontinuing the use. The study is published in the journal Cancer Research.

17 Dec 2020

Azithromycin trial fails to provide evidence of benefit in COVID-19

Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.

16 Dec 2020

Impaired blood vessel and kidney function underlie heart disease risk in people with HIV

A new study has found impaired blood vessel function in those living with human immunodeficiency virus (HIV).

16 Dec 2020

RedHill Biopharma announces promising preliminary results from opaganib study

TEL AVIV, Israel and RALEIGH, NC, December 15, 2020, RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study with opaganib.

15 Dec 2020

Hematoxylin compounds can selectively kill CALR mutant cancer cells

Patients with myeloproliferative neoplasm (MPN), a group of malignant diseases of the bone marrow, often have a carcinogenic mutated form of the calreticulin gene (CALR).

10 Dec 2020

Neutrophils may play a key role in COVID-19-related thrombosis

A team of researchers in Italy have published a study suggesting that rather than platelets, neutrophils could be playing the lead role in thrombotic complications associated with COVID-19.

9 Dec 2020

New guidelines and standards for the treatment of brain tumor complications

The brain can be affected by a number of different types of tumor and this leads to serious complications such as epileptic attacks, brain edema, hemorrhage, or thrombosis.

9 Dec 2020

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

A new study published on the preprint server bioRxiv in December 2020 reveals the role played by certain genetic factors in this group, in particular the FASLG gene belonging to the tumor necrosis factor (TNF) family.

8 Dec 2020

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

A potentially valuable new study discusses the role of lipids in the hyper-inflammatory phenomena that take place within the lungs of patients with severe or critical COVID-19. Involving a large variety of specialized lipids with biological activity, this process includes the generation and release of pro and anti-inflammatory lipids.

8 Dec 2020

Low testosterone can increase risk of severe COVID-19 in males

Researchers from the USA and Saudi Arabia describe the direct correlation between testosterone levels, inflammatory cytokines, disease progression, and worse outcomes in male COVID-19 patients.

4 Dec 2020

Combination of microfluidic technology and blood flow research may help understand cardiovascular diseases

Announcing a new publication for BIO Integration journal. In this article the authors Meng Zhang, Wu Zhang, Zihuang Wang and Weiqian Chen from Sun Yat-Sen University, Guangzhou, China, Harvard University, Cambridge, MA, USA and Guangzhou University, Guangzhou, China review viscoelastic flow mixing in microfluidics.

3 Dec 2020

Innovative, integrated approaches can improve cardiovascular health, shows study

For cardiovascular health to improve in the general population, healthcare systems will need to collect and assess treatment data, establish collaboration between researchers and healthcare professionals, and evolve patient care in real-time based on those data.

3 Dec 2020

Autoantigen may help prevent and treat cardiovascular disease

$Z-drugs can increase risk of falls, fractures, and stroke in dementia patients$

Z-drugs can increase risk of falls, fractures, and stroke in dementia patients

Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia - according to research from the University of East Anglia.

24 Nov 2020

Thrombosis News and Research

Latest Thrombosis News and Research

Engineered nanodroplets and ultrasound 'drill' can help eliminate tough blood clots

FDA authorizes first device to treat patients with walled-off pancreatic necrosis

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

New toolkit aims to maximize high-quality collection of thrombosis data in COVID-19 clinical studies

Oral contraceptives offer a protective effect against common gynecological cancers

Azithromycin trial fails to provide evidence of benefit in COVID-19

Impaired blood vessel and kidney function underlie heart disease risk in people with HIV

RedHill Biopharma announces promising preliminary results from opaganib study

Hematoxylin compounds can selectively kill CALR mutant cancer cells

Neutrophils may play a key role in COVID-19-related thrombosis

New guidelines and standards for the treatment of brain tumor complications

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

Low testosterone can increase risk of severe COVID-19 in males

Combination of microfluidic technology and blood flow research may help understand cardiovascular diseases

Innovative, integrated approaches can improve cardiovascular health, shows study

Autoantigen may help prevent and treat cardiovascular disease

Asymptomatic patients have higher SARS-CoV-2 viral loads than symptomatic patients, study says

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Z-drugs can increase risk of falls, fractures, and stroke in dementia patients

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Thrombosis News and Research

Latest Thrombosis News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in